These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 20496805

  • 1. [Clinical and laboratory evaluation of efficiency of Helicobacter pylori eradication].
    Drygina LB, Poiarkova NA, Sablin OA.
    Eksp Klin Gastroenterol; 2010; (2):27-31. PubMed ID: 20496805
    [Abstract] [Full Text] [Related]

  • 2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV.
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [Abstract] [Full Text] [Related]

  • 3. [The clinical significance of GastroPanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer].
    Adamczyk M, Peczek Ł, Rudnicki C, Nawrot B, Stec-Michalska K.
    Pol Merkur Lekarski; 2013 Sep; 35(207):141-7. PubMed ID: 24224450
    [Abstract] [Full Text] [Related]

  • 4. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T, Miwa H, Nomura T, Asaoka D, Kurosawa A, Sakamoto N, Abe S, Hojo M, Terai T, Ogihara T, Sato N.
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [Abstract] [Full Text] [Related]

  • 5. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C, Bölükbaş FF, Ovünç O, Kiliç G, Dalay R, Güven H, Uras F, Yardimci TK, Sökmen MH, Agan AF, Pişkinpaşa N.
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [Abstract] [Full Text] [Related]

  • 6. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.
    Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H.
    Helicobacter; 2007 Dec; 12(6):605-8. PubMed ID: 18001400
    [Abstract] [Full Text] [Related]

  • 7. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V, Mela GS, Zentilin P, Lapertosa G, Bisso G, Mele MR, Pivari M, Mansi C, Vigneri S, Celle G.
    Ital J Gastroenterol Hepatol; 1999 Dec; 31(1):4-8. PubMed ID: 10091096
    [Abstract] [Full Text] [Related]

  • 8. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT, Miki K, Walsh JH, Graham DP, Asaka M, Graham DY.
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [Abstract] [Full Text] [Related]

  • 9. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy].
    Fujisawa T, Kumagai T, Goto A, Fujimori K, Akamatsu T, Kiyosawa K.
    Nihon Rinsho; 1999 Jan; 57(1):101-6. PubMed ID: 10036944
    [Abstract] [Full Text] [Related]

  • 10. Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: prospective 4-year study.
    Di Mario F, Moussa AM, Dal Bò N, Caruana P, Pilotto A, Cavallaro LG, Cavestro GM, Iori V, Merli R, Franzé A, Rugge M.
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1661-6. PubMed ID: 16246182
    [Abstract] [Full Text] [Related]

  • 11. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S, Matsukura N, Matsuda N, Tsuchiya S, Naito Z, Tajiri T.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [Abstract] [Full Text] [Related]

  • 12. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 13. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study.
    Sipponen P, Ranta P, Helske T, Kääriäinen I, Mäki T, Linnala A, Suovaniemi O, Alanko A, Härkönen M.
    Scand J Gastroenterol; 2002 Jul; 37(7):785-91. PubMed ID: 12190091
    [Abstract] [Full Text] [Related]

  • 14. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G.
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [Abstract] [Full Text] [Related]

  • 15. Basal and stimulated gastrin and pepsinogen levels after eradication of Helicobacter pylori: a 1-year follow-up study.
    Gisbert JP, Boixeda D, Al-Mostafa A, Vila T, de Rafael L, Alvarez Baleriola I, de Argila CM, Abraira V.
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):189-200. PubMed ID: 10102232
    [Abstract] [Full Text] [Related]

  • 16. Changes in the histology and function of gastric mucosa and in Helicobacter pylori colonization during a long-term follow-up period after vagotomy in duodenal ulcer patients.
    Peetsalu M, Valle J, Härkönen M, Maaroos HI, Peetsalu A.
    Hepatogastroenterology; 2005 Feb; 52(63):785-91. PubMed ID: 15966205
    [Abstract] [Full Text] [Related]

  • 17. Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.
    Leja M, Lapina S, Polaka I, Rudzite D, Vilkoite I, Daugule I, Belkovets A, Pimanov S, Makarenko J, Tolmanis I, Lejnieks A, Boka V, Rumba-Rozenfelde I, Vikmanis U.
    Medicina (Kaunas); 2014 Feb; 50(1):8-13. PubMed ID: 25060199
    [Abstract] [Full Text] [Related]

  • 18. GastroPanel: evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children.
    Guariso G, Basso D, Bortoluzzi CF, Meneghel A, Schiavon S, Fogar P, Farina M, Navaglia F, Greco E, Mescoli C, Zambon CF, Plebani M.
    Clin Chim Acta; 2009 Apr; 402(1-2):54-60. PubMed ID: 19135434
    [Abstract] [Full Text] [Related]

  • 19. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
    Chang YW, Oh HC, Jang JY, Hwangbo Y, Lee JW, Lee HJ, Joo KR, Dong SH, Kim SS, Kim HJ, Kim BH, Chang R.
    Scand J Gastroenterol; 2008 Apr; 43(10):1184-93. PubMed ID: 18609140
    [Abstract] [Full Text] [Related]

  • 20. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Apr; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.